A Study of Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers
Clinical trial NCT06611345 · RECRUITING
Trial details
- NCT number
- NCT06611345
- Sponsor
- Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-21
- Primary completion
- 2026-10-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.